Artykuły w czasopismach na temat „Mesenchymal stromal cells derivedfrom Wharton's Jelly”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Mesenchymal stromal cells derivedfrom Wharton's Jelly”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Badraiq, H., A. Cvoro, A. Galleu, M. Simon, F. Dazzi i D. Ilic. "Maternal obesity alters characteristics of Wharton's Jelly mesenchymal stromal cells". Cytotherapy 19, nr 5 (maj 2017): S160. http://dx.doi.org/10.1016/j.jcyt.2017.02.248.
Pełny tekst źródłaLopez-Rodriguez, Y., E. Trevino i M. L. Weiss. "Wharton's jelly mesenchymal stromal cells (WJCs) as immunoregulators in allogeneic transplantation". Placenta 32 (październik 2011): S329. http://dx.doi.org/10.1016/j.placenta.2011.07.040.
Pełny tekst źródłaMajumdar, D., R. Bhonde i I. Datta. "Influence of ischemic microenvironment on human Wharton's Jelly mesenchymal stromal cells". Placenta 34, nr 8 (sierpień 2013): 642–49. http://dx.doi.org/10.1016/j.placenta.2013.04.021.
Pełny tekst źródłaBatsali, A., C. G. Pontikoglou, E. Kouvidi, A. Damianaki, M. Kastrinaki i H. A. Papadaki. "Direct comparison of Wharton's Jelly and bone marrow mesenchymal stem/stromal cells". Cytotherapy 16, nr 4 (kwiecień 2014): S73—S74. http://dx.doi.org/10.1016/j.jcyt.2014.01.272.
Pełny tekst źródłaAljitawi, Omar S., Yinghua Xiao, Da Zhang, Lisa Stehno-Bittel, Rama Garimella, Richard A. Hopkins i Michael S. Detamore. "Generating CK19-Positive Cells with Hair-Like Structures from Wharton's Jelly Mesenchymal Stromal Cells". Stem Cells and Development 22, nr 1 (styczeń 2013): 18–26. http://dx.doi.org/10.1089/scd.2012.0184.
Pełny tekst źródłaPanta, W., H. Kunkanjanawan, T. Kunkanjanawan, R. Parnpai i V. Khemarangsan. "Stability characteristic of cryopreserved human umbilical cord wharton's jelly–derived mesenchymal stromal cells". Cytotherapy 21, nr 5 (maj 2019): S86. http://dx.doi.org/10.1016/j.jcyt.2019.03.509.
Pełny tekst źródłaMalagon, A., M. Hautefeuille, G. Piñon i A. Castell. "Osteogenic potential of Wharton's jelly mesenchymal stromal cells cultured on a biomimetic scaffold". Cytotherapy 22, nr 5 (maj 2020): S204—S205. http://dx.doi.org/10.1016/j.jcyt.2020.04.083.
Pełny tekst źródłaDavies, John E., John T. Walker i Armand Keating. "Concise Review: Wharton's Jelly: The Rich, but Enigmatic, Source of Mesenchymal Stromal Cells". STEM CELLS Translational Medicine 6, nr 7 (10.05.2017): 1620–30. http://dx.doi.org/10.1002/sctm.16-0492.
Pełny tekst źródłaZhang, Ying-Nan, Pu-Chang Lie i Xing Wei. "Differentiation of mesenchymal stromal cells derived from umbilical cord Wharton's jelly into hepatocyte-like cells". Cytotherapy 11, nr 5 (styczeń 2009): 548–58. http://dx.doi.org/10.1080/14653240903051533.
Pełny tekst źródłaLupatov, A. Yu, R. Yu Saryglar, V. D. Chuprynin, S. V. Pavlovich i K. N. Yarygin. "Comparison of the expression profile of surface molecular markers on mesenchymal stromal cell cultures isolated from human endometrium and umbilical cord". Biomeditsinskaya Khimiya 63, nr 1 (styczeń 2017): 85–90. http://dx.doi.org/10.18097/pbmc20176301085.
Pełny tekst źródłaDatta, Indrani, Swati Mishra, Lipsa Mohanty, Sunitha Pulikkot i Preeti G. Joshi. "Neuronal plasticity of human Wharton's jelly mesenchymal stromal cells to the dopaminergic cell type compared with human bone marrow mesenchymal stromal cells". Cytotherapy 13, nr 8 (wrzesień 2011): 918–32. http://dx.doi.org/10.3109/14653249.2011.579957.
Pełny tekst źródłaShohara, Ryutaro, Akihito Yamamoto, Sachiko Takikawa, Akira Iwase, Hideharu Hibi, Fumitaka Kikkawa i Minoru Ueda. "Mesenchymal stromal cells of human umbilical cord Wharton's jelly accelerate wound healing by paracrine mechanisms". Cytotherapy 14, nr 10 (wrzesień 2012): 1171–81. http://dx.doi.org/10.3109/14653249.2012.706705.
Pełny tekst źródłaGovindasamy, V., M. Chai, Z. Lee, K. Then, S. Cheong i N. Abu Kasim. "Wharton's jelly mesenchymal stromal cells express pancreatic lineage markers upon culturing in hanging drop technique". Cytotherapy 20, nr 5 (maj 2018): S39. http://dx.doi.org/10.1016/j.jcyt.2018.02.096.
Pełny tekst źródłaManochantr, S., Y. U-pratya, P. Kheolamai, S. Rojphisan, M. Chayosumrit, C. Tantrawatpan, A. Supokawej i S. Issaragrisil. "Immunosuppressive properties of mesenchymal stromal cells derived from amnion, placenta, Wharton's jelly and umbilical cord". Internal Medicine Journal 43, nr 4 (kwiecień 2013): 430–39. http://dx.doi.org/10.1111/imj.12044.
Pełny tekst źródłaVivas Pradillo, D., L. Martorell, R. Cabrera-Pérez, C. Mirabel, C. Frago, J. Ayats, M. Monguió-Tortajada i in. "Toward the use of Wharton's Jelly-derived multipotent Mesenchymal Stromal Cells in bone Tissue Engineering strategies". Cytotherapy 20, nr 5 (maj 2018): S55. http://dx.doi.org/10.1016/j.jcyt.2018.02.152.
Pełny tekst źródłaSV, Konovalov, Moroz VM, Husakova IV, Deryabina OG i Tochilovskyi AA. "Comparative influence of mesenchymal stromal cells of different origin on DNA fragmentation of neuronal nuclei during ischemia-reperfusion of the somatosensory cortex of the rat brain". Advances in Tissue Engineering & Regenerative Medicine: Open Access 9, nr 1 (18.09.2023): 29–33. http://dx.doi.org/10.15406/atroa.2023.09.00138.
Pełny tekst źródłaWu, Li-Fang, Ni-Na Wang, Yuan-Sheng Liu i Xing Wei. "Differentiation of Wharton's Jelly Primitive Stromal Cells into Insulin-Producing Cells in Comparison with Bone Marrow Mesenchymal Stem Cells". Tissue Engineering Part A 15, nr 10 (październik 2009): 2865–73. http://dx.doi.org/10.1089/ten.tea.2008.0579.
Pełny tekst źródłaAljitawi, Omar S., Peggy Keefe, Lindsey Ott, Dandan Li, Da Zhang, Sunil Abhyankar, Rama Garimella, Joseph McGuirk i Michael Detamore. "A Wharton's Jelly Mesenchymal Stromal Cell Derived 3D Osteogenic Niche Allows for Cord Blood Stem Cell Attachment". Blood 118, nr 21 (18.11.2011): 4813. http://dx.doi.org/10.1182/blood.v118.21.4813.4813.
Pełny tekst źródłaBalasubramanian, Sudha, Parvathy Venugopal, Swathi Sundarraj, Zubaidah Zakaria, Anish Sen Majumdar i Malancha Ta. "Comparison of chemokine and receptor gene expression between Wharton's jelly and bone marrow-derived mesenchymal stromal cells". Cytotherapy 14, nr 1 (styczeń 2012): 26–33. http://dx.doi.org/10.3109/14653249.2011.605119.
Pełny tekst źródłaHou, Tianyong, Jianzhong Xu, Xuehui Wu, Zhao Xie, Fei Luo, Zehua Zhang i Ling Zeng. "Umbilical Cord Wharton's Jelly: A New Potential Cell Source of Mesenchymal Stromal Cells for Bone Tissue Engineering". Tissue Engineering Part A 15, nr 9 (wrzesień 2009): 2325–34. http://dx.doi.org/10.1089/ten.tea.2008.0402.
Pełny tekst źródłaPanta, W., T. Yoisungnern, S. Imsoonthornruksa, S. Suksaweang, M. Ketudat-Cairns i R. Parnpai. "Enhance hepatic differentiation of human Wharton's jelly–derived mesenchymal stromal cells by using sodium butyrate pre-treated". Cytotherapy 21, nr 5 (maj 2019): S83. http://dx.doi.org/10.1016/j.jcyt.2019.03.499.
Pełny tekst źródłaLopez, Yelica. "Evaluating the Impact of Oxygen Concentration and Plating Density on Human Wharton's Jelly-Derived Mesenchymal Stromal Cells". Open Tissue Engineering and Regenerative Medicine Journal 4, nr 1 (30.12.2011): 82–94. http://dx.doi.org/10.2174/1875043501104010082.
Pełny tekst źródłaCason, Carolina, Giuseppina Campisciano, Nunzia Zanotta, Erica Valencic, Serena Delbue, Ramona Bella i Manola Comar. "SV40 Infection of Mesenchymal Stromal Cells From Wharton's Jelly Drives the Production of Inflammatory and Tumoral Mediators". Journal of Cellular Physiology 232, nr 11 (29.12.2016): 3060–66. http://dx.doi.org/10.1002/jcp.25723.
Pełny tekst źródłaChoi, Moran, Hyun-Sun Lee, Purevjargal Naidansaren, Hyun-Kyung Kim, Eunju O, Jung-Ho Cha, Hyun-Young Ahn, Park In Yang, Jong-Chul Shin i Young Ae Joe. "Proangiogenic features of Wharton's jelly-derived mesenchymal stromal/stem cells and their ability to form functional vessels". International Journal of Biochemistry & Cell Biology 45, nr 3 (marzec 2013): 560–70. http://dx.doi.org/10.1016/j.biocel.2012.12.001.
Pełny tekst źródłaGladysz, D., A. Krzywdzinska, M. Murzyn, K. Kapturska, K. K. Hozyasz i T. Oldak. "The influence of Wharton's jelly-derived mesenchymal stromal cells on T regulatory cells in patients with autism spectrum disorder". Cytotherapy 20, nr 5 (maj 2018): S97—S98. http://dx.doi.org/10.1016/j.jcyt.2018.02.287.
Pełny tekst źródłaFrausin, Stefano, Serena Viventi, Lucia Verga Falzacappa, Miriana Jlenia Quattromani, Giampiero Leanza, Alberto Tommasini i Erica Valencic. "Wharton's jelly derived mesenchymal stromal cells: Biological properties, induction of neuronal phenotype and current applications in neurodegeneration research". Acta Histochemica 117, nr 4-5 (maj 2015): 329–38. http://dx.doi.org/10.1016/j.acthis.2015.02.005.
Pełny tekst źródłaNajar, Mehdi, Gordana Raicevic, Hicham Id Boufker, Hussein Fayyad-Kazan, Cécile De Bruyn, Nathalie Meuleman, Dominique Bron, Michel Toungouz i Laurence Lagneaux. "Adipose-Tissue-Derived and Wharton's Jelly–Derived Mesenchymal Stromal Cells Suppress Lymphocyte Responses by Secreting Leukemia Inhibitory Factor". Tissue Engineering Part A 16, nr 11 (listopad 2010): 3537–46. http://dx.doi.org/10.1089/ten.tea.2010.0159.
Pełny tekst źródłaOliver-Vila, Irene, Maria Isabel Coca, Marta Grau-Vorster, Noèlia Pujals-Fonts, Marta Caminal, Alba Casamayor-Genescà, Isabel Ortega i in. "Evaluation of a cell-banking strategy for the production of clinical grade mesenchymal stromal cells from Wharton's jelly". Cytotherapy 18, nr 1 (styczeń 2016): 25–35. http://dx.doi.org/10.1016/j.jcyt.2015.10.001.
Pełny tekst źródłaBoey, K. P., D. S. Lim, C. Ong, J. Mesilamani, K. Tang, M. Li, P. Zhu i T. T. Phan. "Comparison of extraction methods and culture medium for umbilical cord lining- and wharton's jelly-derived mesenchymal stromal cells". Cytotherapy 21, nr 5 (maj 2019): S80. http://dx.doi.org/10.1016/j.jcyt.2019.03.489.
Pełny tekst źródłaHang, Zhao, i Xiao Haijun. "Proliferative, Differentiative, and Immunological Characteristics of Chondro-Differentiated Mesenchymal Stromal Cells Derived from Rabbit Umbilical Cord Wharton's Jelly". Journal of Biomaterials and Tissue Engineering 8, nr 7 (1.07.2018): 1046–52. http://dx.doi.org/10.1166/jbt.2018.1833.
Pełny tekst źródłaLee, Hyun-Sun, Kwang S. Kim, Hee-Suk Lim, Moran Choi, Hyun-Kyung Kim, Hyun-Young Ahn, Jong-Chul Shin i Young Ae Joe. "Priming Wharton's Jelly-Derived Mesenchymal Stromal/Stem Cells With ROCK Inhibitor Improves Recovery in an Intracerebral Hemorrhage Model". Journal of Cellular Biochemistry 116, nr 2 (12.12.2014): 310–19. http://dx.doi.org/10.1002/jcb.24969.
Pełny tekst źródłaSharma, Tulika, Poonam Kumari, Neha Pincha, Naresh Mutukula, Shekhar Saha, Siddhartha S. Jana i Malancha Ta. "Inhibition of non-muscle myosin II leads to G0/G1 arrest of Wharton's jelly-derived mesenchymal stromal cells". Cytotherapy 16, nr 5 (maj 2014): 640–52. http://dx.doi.org/10.1016/j.jcyt.2013.09.003.
Pełny tekst źródłaOppliger, Byron, Marianne S. Joerger-Messerli, Cedric Simillion, Martin Mueller, Daniel V. Surbek i Andreina Schoeberlein. "Mesenchymal stromal cells from umbilical cord Wharton's jelly trigger oligodendroglial differentiation in neural progenitor cells through cell-to-cell contact". Cytotherapy 19, nr 7 (lipiec 2017): 829–38. http://dx.doi.org/10.1016/j.jcyt.2017.03.075.
Pełny tekst źródłaMilazzo, Luisa, Francesca Vulcano, Alessandra Barca, Giampiero Macioce, Emanuela Paldino, Stefania Rossi, Carmela Ciccarelli, Hamisa J. Hassan i Adele Giampaolo. "Cord blood CD34+ cells expanded on Wharton's jelly multipotent mesenchymal stromal cells improve the hematopoietic engraftment in NOD/SCID mice". European Journal of Haematology 93, nr 5 (26.05.2014): 384–91. http://dx.doi.org/10.1111/ejh.12363.
Pełny tekst źródłaBatsali, Aristea, Charalampos Pontikoglou, Elisavet Kouvidi, Athina Damianaki, Aikaterini Stratigi, Maria-Christina Kastrinaki i Helen A. Papadaki. "Comparative Analysis Of Bone Marrow and Wharton’s Jelly Mesenchymal Stem/Stromal Cells". Blood 122, nr 21 (15.11.2013): 1212. http://dx.doi.org/10.1182/blood.v122.21.1212.1212.
Pełny tekst źródłaBatsali, Aristea, Charalampos Pontikoglou, Emmanuel Agrafiotis, Elisavet Kouvidi, Irene Mavroudi, Athina Damianaki, Maria-Christina Kastrinaki i Helen Papadaki. "Emerging Roles of Wisp-1 and SFRP4 in Proliferation and Differentiation Potential of Wharton's Jelly Mesenchymal Stem/Stromal Cells". Blood 124, nr 21 (6.12.2014): 4375. http://dx.doi.org/10.1182/blood.v124.21.4375.4375.
Pełny tekst źródłaDe Bruyn, Cécile, Mehdi Najar, Gordana Raicevic, Nathalie Meuleman, Karlien Pieters, Basile Stamatopoulos, Alain Delforge, Dominique Bron i Laurence Lagneaux. "A Rapid, Simple, and Reproducible Method for the Isolation of Mesenchymal Stromal Cells from Wharton's Jelly Without Enzymatic Treatment". Stem Cells and Development 20, nr 3 (marzec 2011): 547–57. http://dx.doi.org/10.1089/scd.2010.0260.
Pełny tekst źródłaQuaranta, Paola, Daniele Focosi, Marilena Di Iesu, Chiara Cursi, Alessandra Zucca, Michele Curcio, Simone Lapi i in. "Human Wharton's jelly–derived mesenchymal stromal cells engineered to secrete Epstein-Barr virus interleukin-10 show enhanced immunosuppressive properties". Cytotherapy 18, nr 2 (luty 2016): 205–18. http://dx.doi.org/10.1016/j.jcyt.2015.11.011.
Pełny tekst źródłaColl, R., J. Vidal, H. Kumru, J. Benito, M. Valles, N. Ribó, M. Codinach i in. "Intrathecal administration of expanded wharton's jelly mesenchymal stromal cells (WJ-MSC) in chronic traumatic spinal cord injury (SCI) (NCT03003364)". Cytotherapy 20, nr 5 (maj 2018): S33—S34. http://dx.doi.org/10.1016/j.jcyt.2018.02.082.
Pełny tekst źródłaColl, R., J. Vidal, H. Kumru, J. Benito, M. Valles, M. Codinach, M. Blanco i in. "Is HLA matching relevant for treating Spinal Cord Injury with intrathecal administration of expanded Wharton's Jelly Mesenchymal Stromal Cells?" Cytotherapy 22, nr 5 (maj 2020): S26—S27. http://dx.doi.org/10.1016/j.jcyt.2020.03.006.
Pełny tekst źródłaFernández, A. López, I. Carreras Sánchez i J. Vives. "Successful scale up expansion of Wharton's jelly mesenchymal stromal cells in different commercial xeno-free and serum-free media". Cytotherapy 22, nr 5 (maj 2020): S94. http://dx.doi.org/10.1016/j.jcyt.2020.03.162.
Pełny tekst źródłaPochon, Cecile, Romain Perouf, Allan Bertrand, Anne-Béatrice Notarantonio, Naceur Charif, Marcelo De Carvalho Bittencourt, Guillemette Fouquet i in. "IFN-γ Primed Wharton's Jelly Mesenchymal Stromal Cells Inhibit T Cell Proliferation By Synergistic IDO and Mitochondrial Transfer Mechanisms". Blood 140, Supplement 1 (15.11.2022): 4504–5. http://dx.doi.org/10.1182/blood-2022-167814.
Pełny tekst źródłaKaushik, Komal, i Amitava Das. "Cycloxygenase-2 inhibition potentiates trans-differentiation of Wharton's jelly–mesenchymal stromal cells into endothelial cells: Transplantation enhances neovascularization-mediated wound repair". Cytotherapy 21, nr 2 (luty 2019): 260–73. http://dx.doi.org/10.1016/j.jcyt.2019.01.004.
Pełny tekst źródłaWang, Ying, Feng Chen, Bing Gu, Guanghua Chen, Huirong Chang i Depei Wu. "Mesenchymal Stromal Cells as an Adjuvant Treatment for Severe Late-Onset Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation". Acta Haematologica 133, nr 1 (16.08.2014): 72–77. http://dx.doi.org/10.1159/000362530.
Pełny tekst źródłaJing, Bai, Hu Yuan, Wang Yi-Ru, Liu Li-Feng, Chen Jie, Su Shao-Ping i Wang Yu. "Comparison of human amniotic fluid-derived and umbilical cord Wharton's Jelly-derived mesenchymal stromal cells: Characterization and myocardial differentiation capacity". Journal of Geriatric Cardiology 9, nr 2 (20.07.2012): 166–71. http://dx.doi.org/10.3724/sp.j.1263.2011.12091.
Pełny tekst źródłaBai, Jing, i Yu Wang. "COMPARISON OF HUMAN AMNIOTIC FLUID-DERIVED AND UMBILICAL CORD WHARTON'S JELLY-DERIVED MESENCHYMAL STROMAL CELLS: CHARACTERISATION AND MYOCARDIAL DIFFERENTIATION CAPACITY". Heart 98, Suppl 2 (październik 2012): E67.3—E68. http://dx.doi.org/10.1136/heartjnl-2012-302920a.167.
Pełny tekst źródłavan der Garde, Mark, Melissa van Pel, Jose Eduardo Millán Rivero, Alice de Graaf-Dijkstra, Manon C. Slot, Yoshiko Kleinveld, Suzanne M. Watt, Helene Roelofs i Jaap Jan Zwaginga. "Direct Comparison of Wharton's Jelly and Bone Marrow-Derived Mesenchymal Stromal Cells to Enhance Engraftment of Cord Blood CD34+Transplants". Stem Cells and Development 24, nr 22 (15.11.2015): 2649–59. http://dx.doi.org/10.1089/scd.2015.0138.
Pełny tekst źródłaMoreira, Alvaro, Caitlyn Winter, Jooby Joy, Lauryn Winter, Maxwell Jones, Michelle Noronha, Melissa Porter i in. "Intranasal delivery of human umbilical cord Wharton's jelly mesenchymal stromal cells restores lung alveolarization and vascularization in experimental bronchopulmonary dysplasia". STEM CELLS Translational Medicine 9, nr 2 (27.11.2019): 221–34. http://dx.doi.org/10.1002/sctm.18-0273.
Pełny tekst źródłaVulcano, Francesca, Luisa Milazzo, Carmela Ciccarelli, Adriana Eramo, Giovanni Sette, Annunziata Mauro, Giampiero Macioce i in. "Wharton's jelly mesenchymal stromal cells have contrasting effects on proliferation and phenotype of cancer stem cells from different subtypes of lung cancer". Experimental Cell Research 345, nr 2 (lipiec 2016): 190–98. http://dx.doi.org/10.1016/j.yexcr.2016.06.003.
Pełny tekst źródłavan der Garde, Mark, Melissa Van Pel, Jose Millan Rivero, Alice de Graaf-Dijkstra, Manon Slot, Yoshiko Kleinveld, Suzanne Watt, Helene Roelofs i Jaap Jan Zwaginga. "Direct Comparison of Wharton Jelly and Bone Marrow Derived Mesenchymal Stromal Cells to Enhance Engraftment of Cord Blood CD34+ Transplants". Blood 126, nr 23 (3.12.2015): 5410. http://dx.doi.org/10.1182/blood.v126.23.5410.5410.
Pełny tekst źródła